BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 31502646)

  • 1. Purine Metabolites and Carnitine Biosynthesis Intermediates Are Biomarkers for Incident Type 2 Diabetes.
    Ottosson F; Smith E; Gallo W; Fernandez C; Melander O
    J Clin Endocrinol Metab; 2019 Oct; 104(10):4921-4930. PubMed ID: 31502646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma Metabolites Associate with All-Cause Mortality in Individuals with Type 2 Diabetes.
    Ottosson F; Smith E; Fernandez C; Melander O
    Metabolites; 2020 Jul; 10(8):. PubMed ID: 32751974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dimethylguanidino Valerate: A Lifestyle-Related Metabolite Associated With Future Coronary Artery Disease and Cardiovascular Mortality.
    Ottosson F; Ericson U; Almgren P; Smith E; Brunkwall L; Hellstrand S; Nilsson PM; Orho-Melander M; Fernandez C; Melander O
    J Am Heart Assoc; 2019 Oct; 8(19):e012846. PubMed ID: 31533499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The association between plasma metabolites and future risk of all-cause mortality.
    Yan Y; Smith E; Melander O; Ottosson F
    J Intern Med; 2022 Nov; 292(5):804-815. PubMed ID: 35796403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The gut microbiota-related metabolite phenylacetylglutamine associates with increased risk of incident coronary artery disease.
    Ottosson F; Brunkwall L; Smith E; Orho-Melander M; Nilsson PM; Fernandez C; Melander O
    J Hypertens; 2020 Dec; 38(12):2427-2434. PubMed ID: 32665522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multicohort Metabolomics Analysis Discloses 9-Decenoylcarnitine to Be Associated With Incident Atrial Fibrillation.
    Lind L; Salihovic S; Sundström J; Broeckling CD; Magnusson PK; Prenni J; Fall T; Ärnlöv J
    J Am Heart Assoc; 2021 Jan; 10(2):e017579. PubMed ID: 33399003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma metabolites associated with type 2 diabetes in a Swedish population: a case-control study nested in a prospective cohort.
    Shi L; Brunius C; Lehtonen M; Auriola S; Bergdahl IA; Rolandsson O; Hanhineva K; Landberg R
    Diabetologia; 2018 Apr; 61(4):849-861. PubMed ID: 29349498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered Asparagine and Glutamate Homeostasis Precede Coronary Artery Disease and Type 2 Diabetes.
    Ottosson F; Smith E; Melander O; Fernandez C
    J Clin Endocrinol Metab; 2018 Aug; 103(8):3060-3069. PubMed ID: 29788285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-targeted urine metabolomics and associations with prevalent and incident type 2 diabetes.
    Salihovic S; Broeckling CD; Ganna A; Prenni JE; Sundström J; Berne C; Lind L; Ingelsson E; Fall T; Ärnlöv J; Nowak C
    Sci Rep; 2020 Oct; 10(1):16474. PubMed ID: 33020500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrated biomarker for type 2 diabetes mellitus and impaired fasting glucose based on metabolomics analysis using ultra-high performance liquid chromatography quadrupole-Orbitrap high-resolution accurate mass spectrometry.
    Long J; Liu L; Jia Q; Yang Z; Sun Z; Yan C; Yan D
    Rapid Commun Mass Spectrom; 2020 Jun; 34(12):e8779. PubMed ID: 32159245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma Lipidome and Prediction of Type 2 Diabetes in the Population-Based Malmö Diet and Cancer Cohort.
    Fernandez C; Surma MA; Klose C; Gerl MJ; Ottosson F; Ericson U; Oskolkov N; Ohro-Melander M; Simons K; Melander O
    Diabetes Care; 2020 Feb; 43(2):366-373. PubMed ID: 31818810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma metabolomics identified novel metabolites associated with risk of type 2 diabetes in two prospective cohorts of Chinese adults.
    Qiu G; Zheng Y; Wang H; Sun J; Ma H; Xiao Y; Li Y; Yuan Y; Yang H; Li X; Min X; Zhang C; Xu C; Jiang Y; Zhang X; He M; Yang M; Hu Z; Tang H; Shen H; Hu FB; Pan A; Wu T
    Int J Epidemiol; 2016 Oct; 45(5):1507-1516. PubMed ID: 27694567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LC/MS-Based Untargeted Metabolomics Analysis in Women with Morbid Obesity and Associated Type 2 Diabetes Mellitus.
    Auguet T; Bertran L; Capellades J; Abelló S; Aguilar C; Sabench F; Del Castillo D; Correig X; Yanes O; Richart C
    Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-targeted metabolomics combined with genetic analyses identifies bile acid synthesis and phospholipid metabolism as being associated with incident type 2 diabetes.
    Fall T; Salihovic S; Brandmaier S; Nowak C; Ganna A; Gustafsson S; Broeckling CD; Prenni JE; Kastenmüller G; Peters A; Magnusson PK; Wang-Sattler R; Giedraitis V; Berne C; Gieger C; Pedersen NL; Ingelsson E; Lind L
    Diabetologia; 2016 Oct; 59(10):2114-24. PubMed ID: 27406814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolomic profiles associated with all-cause mortality in the Women's Health Initiative.
    Balasubramanian R; Paynter NP; Giulianini F; Manson JE; Zhao Y; Chen JC; Vitolins MZ; Albert CA; Clish C; Rexrode KM
    Int J Epidemiol; 2020 Feb; 49(1):289-300. PubMed ID: 31651959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Association Between Acylcarnitine Metabolites and Cardiovascular Disease in Chinese Patients With Type 2 Diabetes Mellitus.
    Zhao S; Feng XF; Huang T; Luo HH; Chen JX; Zeng J; Gu M; Li J; Sun XY; Sun D; Yang X; Fang ZZ; Cao YF
    Front Endocrinol (Lausanne); 2020; 11():212. PubMed ID: 32431666
    [No Abstract]   [Full Text] [Related]  

  • 17. Walnut Consumption, Plasma Metabolomics, and Risk of Type 2 Diabetes and Cardiovascular Disease.
    Guasch-Ferré M; Hernández-Alonso P; Drouin-Chartier JP; Ruiz-Canela M; Razquin C; Toledo E; Li J; Dennis C; Wittenbecher C; Corella D; Estruch R; Fitó M; Ros E; Babio N; Bhupathiraju SN; Clish CB; Liang L; Martínez-González MA; Hu FB; Salas-Salvadó J
    J Nutr; 2021 Feb; 151(2):303-311. PubMed ID: 33382410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A healthy dietary metabolic signature is associated with a lower risk for type 2 diabetes and coronary artery disease.
    Smith E; Ericson U; Hellstrand S; Orho-Melander M; Nilsson PM; Fernandez C; Melander O; Ottosson F
    BMC Med; 2022 Apr; 20(1):122. PubMed ID: 35443726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma metabolites associated with healthy Nordic dietary indexes and risk of type 2 diabetes-a nested case-control study in a Swedish population.
    Shi L; Brunius C; Johansson I; Bergdahl IA; Lindahl B; Hanhineva K; Landberg R
    Am J Clin Nutr; 2018 Sep; 108(3):564-575. PubMed ID: 30060042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perturbation of serum metabolome in relation to type 2 diabetes mellitus and urinary levels of phthalate metabolites and bisphenols.
    Duan Y; Sun H; Yao Y; Han L; Chen L
    Environ Int; 2021 Oct; 155():106609. PubMed ID: 33965767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.